CIK 0001759655 · Large accelerated filer
Privia Health Group, Inc.
Sign in to watch- Ticker
- PRVA
- Exchange
- Nasdaq
- Industry
- Services-Health Services
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 571-366-8850
- Business address
- 950 N. GLEBE RD., SUITE 700, ARLINGTON, VA, 22203
- Former names
- PH Group Parent Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-01 | Ernest Opella Finley Director | Grant or award | +6,350 | 6,350 | ||
| 2026-07-09 | Mountcastle David EVP & Chief Financial Officer | Sale 10b5-1 | −21,275 | $27.67 | $589K | 164,853 |
| 2026-07-07 | Mountcastle David EVP & Chief Financial Officer | Sale 10b5-1 | −600 | $27.57 | $17K | 186,128 |
| 2026-07-06 | Morris Matthew Shawn Director | Option exercise 10b5-1 | +53,722 | $2.00 | $107K | 130,373 |
| 2026-07-06 | Morris Matthew Shawn Director | Sale 10b5-1 | −53,722 | $27.24 | $1.5M | 68,188 |
| 2026-07-06 | Morris Matthew Shawn Director | Option exercise · Stock Option (Right to Purchase) 10b5-1 | −53,722 | 3,274,622 | ||
| 2026-07-02 | Mountcastle David EVP & Chief Financial Officer | Sale 10b5-1 | −24,734 | $27.50 | $680K | 186,728 |
| 2026-07-02 | Morris Matthew Shawn Director | Option exercise 10b5-1 | +59,037 | $2.00 | $118K | 135,688 |
| 2026-07-02 | Morris Matthew Shawn Director | Sale 10b5-1 | −59,037 | $27.33 | $1.6M | 76,651 |
| 2026-07-02 | Morris Matthew Shawn Director | Option exercise · Stock Option (Right to Purchase) 10b5-1 | −59,037 | 3,328,344 | ||
| 2026-07-01 | Morris Matthew Shawn Director | Option exercise 10b5-1 | +82,675 | $2.00 | $165K | 159,326 |
| 2026-07-01 | Morris Matthew Shawn Director | Sale 10b5-1 | −45,634 | $26.52 | $1.2M | 113,692 |
| 2026-07-01 | Morris Matthew Shawn Director | Sale 10b5-1 | −37,041 | $26.93 | $998K | 76,651 |
| 2026-07-01 | Morris Matthew Shawn Director | Option exercise · Stock Option (Right to Purchase) 10b5-1 | −82,675 | 3,387,381 | ||
| 2026-06-30 | Morris Matthew Shawn Director | Option exercise 10b5-1 | +52,823 | $2.00 | $106K | 129,474 |
| 2026-06-30 | Morris Matthew Shawn Director | Sale 10b5-1 | −52,823 | $25.72 | $1.4M | 76,651 |
| 2026-06-30 | Morris Matthew Shawn Director | Option exercise · Stock Option (Right to Purchase) 10b5-1 | −52,823 | 3,470,056 | ||
| 2026-06-29 | Morris Matthew Shawn Director | Option exercise 10b5-1 | +63,212 | $2.00 | $126K | 139,863 |
| 2026-06-29 | Morris Matthew Shawn Director | Sale 10b5-1 | −63,212 | $25.33 | $1.6M | 76,651 |
| 2026-06-29 | Morris Matthew Shawn Director | Option exercise · Stock Option (Right to Purchase) 10b5-1 | −63,212 | 3,522,879 |
Page 1 of 11 · 214 trades